Home › Research › Vascular contributions
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
Berislav V. Zloković. Nature reviews. Neuroscience, 2011-11-03
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
This article examines mechanisms of blood-brain barrier dysfunction in neurodegenerative disorders, notably Alzheimer's disease, and highlights therapeutic opportunities relating to these neurovascular deficits. It describes how the neurovascular unit controls blood-brain barrier permeability, cerebral blood flow, and the neuronal milieu. Furthermore, the text explains that barrier dysfunction is associated with the accumulation of toxic molecules, reduced blood flow, and hypoxia, which may contribute to neuronal degeneration.
What this study adds
Evidence grade: Low
This is a narrative review. Covers neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. It concerns how blood-vessel-related routes may contribute to nerve cell loss, and reports no treatment.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Zloković, B. V. (2011). Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nature reviews. Neuroscience. https://doi.org/10.1038/nrn3114
Vancouver
Zloković BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nature reviews. Neuroscience. 2011. doi:10.1038/nrn3114. PMID: 22048062.
BibTeX
@article{zlokovic2011-22048062,
author = {Zloković, Berislav V.},
title = {{Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders}},
journal = {Nature reviews. Neuroscience},
year = {2011},
doi = {10.1038/nrn3114},
pmid = {22048062},
url = {https://doi.org/10.1038/nrn3114}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Why it matters
Covers neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. It concerns how blood-vessel-related routes may contribute to nerve cell loss, and reports no treatment.
Study details
- Evidence strengthLow
How this study scored 57/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Nature reviews. Neuroscience) |
| Journal's citation record | 4 / 4 | Nature reviews. Neuroscience: journal h-index 572 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2011 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 7 / 7 | Cited 2,967 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 174.5 citations a year over 17 year(s) since 2011 |
| Impact for its field and year | 3 / 6 | Cited 6.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 5 / 6 | Cited by 101 other studies in this library |
| Still being cited | 4 / 4 | Cited 692 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Berislav V. Zloković: h-index 118 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Southern California: institution h-index 1,521 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 22048062) |
| Free to read | 2 / 2 | Free to read |
| Total | 57 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 25.
Later studies that cite this one
101 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Vascular contributions from nearby years
Also in Vascular contributions
53 studies in the library are filed under Vascular contributions with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Vascular contributions hub.